首页> 外文OA文献 >Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

【2h】

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

机译：表现状态是晚期软组织肉瘤患者早期死亡的最有力危险因素欧洲癌症研究和治疗组织–软组织和骨肉瘤小组（STBSG）和法国肉瘤小组（FSG）的研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Penel, N; Glabbeke, M V; Mathoulin-Pelissier, S; Judson, I; Sleijfer, S; Bui, B; Schoffski, P; Ouali, M; Marreaud, S; Brouste, V; Duhamel, A; Hohenberger, P; Blay, J-Y;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer |[ndash]| Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study [J] . N Penel, M V Glabbeke, S Mathoulin-Pelissier, British Journal of Cancer . 2011,第10期

机译：在晚期软组织肉瘤患者中，工作状态是最重要的早期死亡危险因素欧洲癌症研究与治疗组织| [ndash] |软组织和骨肉瘤组（STBSG）和法国肉瘤组（FSG）的研究
2. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). [J] . Sleijfer S, Ouali M, van Glabbeke European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2010,第1期

机译：成年晚期软组织肉瘤成年患者接受一线含异环磷酰胺一线化疗的结果的预后和预测因素：对欧洲软组织癌症研究和治疗组织和骨肉瘤组织（EORTC）进行的大系列研究的回顾性分析-STBSG）。
3. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) [J] . Lindner Lars H., Litiere Saskia, Sleijfer Stefan, International Journal of Cancer =: Journal International du Cancer . 2018,第12期

机译：软组织肉瘤患者肺转移患者的预后因素仅接受一线化疗，探讨欧洲癌症软组织和骨肉瘤组研究和治疗组织的探索性，回顾性分析（EORTC-STBSG）
4. Femoral Fracture Risk Assessment after Intensity Modulated Radiation Therapy (IMRT) for the Treatment of Soft Tissue Sarcoma Using a Novel Mathematical Model [C] . Song, Yan, Wang, Engineering in Medicine and Biology Society, 2006 Annual International Conference of the IEEE . 2006

机译：应用新型数学模型进行强度调制放射治疗（IMRT）治疗软组织肉瘤后的股骨骨折风险评估
5. Near-Infrared Spectroscopy to Assess Exercise-Induced Changes in Skeletal Muscle Oxygenation in Patients with Soft Tissue Sarcoma: A Preliminary Investigation [D] . Hoselton, Andrew Lewis. 2021

机译：近红外光谱，评估软组织肉瘤患者骨骼肌氧合的运动诱导的变化：初步调查
6. Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study [O] . N Penel, M V Glabbeke, S Mathoulin-Pelissier, 2011

机译：表现状态是晚期软组织肉瘤患者早期死亡的最有力危险因素欧洲癌症研究和治疗组织–软组织和骨肉瘤小组（STBSG）和法国肉瘤小组（FSG）的研究
7. Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study [O] . Penel, N, Glabbeke, M. V, Mathoulin-Pelissier, S, 2011

机译：在晚期软组织肉瘤患者中，工作状态是最重要的早期死亡风险因素欧洲癌症研究和治疗组织-软组织和骨肉瘤组（STBSG）和法国肉瘤组（FSG）研究

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

著录项

相似文献

相关主题

期刊订阅